#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11164	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2006	547.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1414	1414	C	609	C	591	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11164	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2006	547.4	0	HET	.	.	.	C481T	.	481	481	C	711	711	C	632	C,T	312,313	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21018	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3583	583.4	0	.	n	.	0	T695C	SNP	695	695	T	1041	1041	C	651	C,T,G	634,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21018	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3583	583.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	1984	1984	G	635	G,A	439,185	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21018	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3583	583.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2317	2317	C	691	C,A,T	674,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21018	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3583	583.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2391	2391	A	698	A,G	681,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21018	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3583	583.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2943	2943	C	599	C,T	588,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1434	folP	855	855	100.0	folP.l15.c17.ctg.1	1608	88.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1081	1083	AGC	148;145;143	A;G,T;C	145;142,1;138	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3978	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3518	112.8	1	SNP	p	S91F	1	.	.	271	273	TTC	593	595	TTC	144;141;142	T;T;C	140;138;135	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3978	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3518	112.8	1	SNP	p	D95G	1	.	.	283	285	GGC	605	607	GGC	139;138;138	G,C;G;C	132,1;134;134	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3978	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3518	112.8	1	SNP	p	G95N	0	.	.	283	285	GGC	605	607	GGC	139;138;138	G,C;G;C	132,1;134;134	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1244	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1307	93.9	1	SNP	p	G45D	0	.	.	133	135	GGC	423	425	GGC	142;142;143	G;G;C	142;140;140	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	688	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	927	73.3	0	.	n	.	0	A197.	DEL	197	197	A	505	505	A	141	A	138	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4060	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3034	133.2	1	SNP	p	D86N	0	.	.	256	258	GAC	586	588	GAC	155;155;158	G;A;C	151;148;154	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4060	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3034	133.2	1	SNP	p	R87I	0	.	.	259	261	CGT	589	591	CGT	157;159;157	C,A;G,A;T	152,1;151,1;150	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4060	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3034	133.2	1	SNP	p	R87W	0	.	.	259	261	CGT	589	591	CGT	157;159;157	C,A;G,A;T	152,1;151,1;150	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4060	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3034	133.2	1	SNP	p	S87R	1	.	.	259	261	CGT	589	591	CGT	157;159;157	C,A;G,A;T	152,1;151,1;150	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4060	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3034	133.2	1	SNP	p	S88P	0	.	.	262	264	TCC	592	594	TCC	156;154;157	T;C;C	150;150;153	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3032	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2704	111.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1629	1631	GGC	151;146;143	G,T;G;C	143,1;141;137	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2934	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2481	117.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1283	1285	GCC	156;157;160	G;C;C	150;154;154	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2934	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2481	117.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1286	1288	ATG	160;160;159	A;T;G	156;156;155	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2934	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2481	117.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1298	1300	ACC	152;152;151	A;C;C	148;148;148	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2934	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2481	117.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1298	1300	ACC	152;152;151	A;C;C	148;148;148	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2934	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2481	117.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1799	1801	ACC	160;161;159	A;C;C	151;159;157	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2934	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2481	117.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1853	1855	GCG	160;159;159	G;C,G;G	154;154,1;155	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2934	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2481	117.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1853	1855	GCG	160;159;159	G;C,G;G	154;154,1;155	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2934	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2481	117.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1976	1978	GGT	111;111;109	G;G;T	105;108;105	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2934	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2481	117.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1985	1987	AGC	104;104;103	A;G;C,G	101;102;99,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2934	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2481	117.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2003	2005	CCG	90;90;89	C,G;C;G,A,C	84,1;81;79,1,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4458	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3305	134.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1727	1729	CCG	150;151;151	C;C;G	145;151;144	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2060	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1913	106.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	556	556	C	138	C	129	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2112	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1636	128.4	1	SNP	p	G120K	1	.	.	358	360	AAG	683	685	AAG	159;160;160	A,G;A;G,A	151,1;154;153,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2112	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1636	128.4	1	SNP	p	N121D	0	.	.	361	363	AAC	686	688	AAC	162;163;164	A;A;C,A	157;158;159,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2112	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1636	128.4	1	SNP	p	A121N	1	.	.	361	363	AAC	686	688	AAC	162;163;164	A;A;C,A	157;158;159,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7720	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4864	158.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	848	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1128	74.8	1	SNP	p	V57M	1	.	.	169	171	ATG	567	569	ATG	162;163;165	A;T;G	160;161;161	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
